Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
Jung Wha Chung, Gi Hyun Kim, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim
Clin Mol Hepatol. 2014;20(4):384-391.   Published online 2014 Dec 24     DOI: https://doi.org/10.3350/cmh.2014.20.4.384
Citations to this article as recorded by Crossref logo
Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis
Chiara Mazzarelli, Marcello Vangeli, Aldo Airoldi
Clinical Gastroenterology and Hepatology.2019; 17(4): 797.     CrossRef
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis
Kryssia I. Rodriguez-Castro, Alessandro Vitale, Mariangela Fadin, Sarah Shalaby, Patrizia Zerbinati, Maria Teresa Sartori, Stefano Landi, Irene Pettinari, Fabio Piscaglia, Guohong Han, Patrizia Burra, Paolo Simioni, Marco Senzolo
European Journal of Gastroenterology & Hepatology.2019; 31(1): 34.     CrossRef
Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis
Nicolas M. Intagliata, Stephen H. Caldwell, Armando Tripodi
Gastroenterology.2019; 156(6): 1582.     CrossRef
Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt: a single-center experience
Kerstin Rosenqvist, Charlotte Ebeling Barbier, Fredrik Rorsman, Per Sangfelt, Rickard Nyman
Acta Radiologica.2018; 59(8): 953.     CrossRef
Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy
Junyang Luo, Mingan Li, Youyong Zhang, Haofan Wang, Mingsheng Huang, Zhengran Li, Junwei Chen, Chun Wu, Jiesheng Qian, Shouhai Guan, Zaibo Jiang
European Radiology.2018; 28(9): 3661.     CrossRef
Timing of anticoagulation for portal vein thrombosis in liver cirrhosis: An Italian internist’s perspective
Nicoletta Riva, Walter Ageno
Journal of Translational Internal Medicine.2018; 6(1): 6.     CrossRef
Transient portal vein thrombosis in liver cirrhosis
Xingshun Qi, Xiaozhong Guo, Eric M. Yoshida, Nahum Méndez-Sánchez, Valerio De Stefano, Frank Tacke, Andrea Mancuso, Yasuhiko Sugawara, Sien-Sing Yang, Rolf Teschke, Ankur Arora, Dominique-Charles Valla
BMC Medicine.2018;[Epub]     CrossRef
Oral Anticoagulation in Patients With Liver Disease
Arman Qamar, Muthiah Vaduganathan, Norton J. Greenberger, Robert P. Giugliano
Journal of the American College of Cardiology.2018; 71(19): 2162.     CrossRef
Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis
Tomas Artaza, Miriam Lopes, Marta Romero, Ana-Zaida Gómez, Gema de la Cruz, Juan José Sánchez, Concepción González, Rafael Gómez
Gastroenterología y Hepatología.2018; 41(10): 611.     CrossRef
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis
Marco Senzolo, Nicoletta Riva, Francesco Dentali, Kryssia Rodriguez-Castro, Maria Teresa Sartori, Soo-Mee Bang, Ida Martinelli, Sam Schulman, Adriano Alatri, Jan Beyer-Westendorf, Matteo Nicola Dario Di Minno, Walter Ageno
Clinical and Translational Gastroenterology.2018; 9(8): e176.     CrossRef
Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
Stefania Basili, Daniele Pastori, Valeria Raparelli, Francesco Violi
Therapeutic Advances in Gastroenterology.2018; 11: 175628481879356.     CrossRef
Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis
Tomas Artaza, Miriam Lopes, Marta Romero, Ana-Zaida Gómez, Gema de la Cruz, Juan José Sánchez, Concepción González, Rafael Gómez
Gastroenterología y Hepatología (English Edition).2018; 41(10): 611.     CrossRef
Anticoagulation in chronic liver disease
Ameet Dhar, Benjamin H. Mullish, Mark R. Thursz
Journal of Hepatology.2017; 66(6): 1313.     CrossRef
Warfarin
Reactions Weekly.2017; 1649(1): 249.     CrossRef
Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation
Andrea Mancuso
Current Hepatology Reports.2017; 16(2): 158.     CrossRef
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis
Lorenzo Loffredo, Daniele Pastori, Alessio Farcomeni, Francesco Violi
Gastroenterology.2017; 153(2): 480.     CrossRef
Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis
Hui Chen, Lei Liu, Xingshun Qi, Chuangye He, Feifei Wu, Daiming Fan, Guohong Han
European Journal of Gastroenterology & Hepatology.2016; 28(1): 82.     CrossRef
Nontumoral portal vein thrombosis in patients awaiting liver transplantation
Hui Chen, Fanny Turon, Virginia Hernández-Gea, Josep Fuster, Angeles Garcia-Criado, Marta Barrufet, Anna Darnell, Constantino Fondevila, Juan Carlos Garcia-Valdecasas, Juan Carlos Garcia-Pagán
Liver Transplantation.2016; 22(3): 352.     CrossRef
Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?
Aaron Liew, James Douketis
Internal and Emergency Medicine.2016; 11(8): 1037.     CrossRef
Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment
Alessandra Dell’Era, Susana Seijo
Expert Opinion on Orphan Drugs.2016; 4(9): 927.     CrossRef
Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver
Kerstin Rosenqvist, Lars-Gunnar Eriksson, Fredrik Rorsman, Per Sangfelt, Rickard Nyman
Acta Radiologica.2016; 57(5): 572.     CrossRef
Optimal Management of Portal Vein Thrombosis in Patients with Liver Cirrhosis: a Review
Geneviève Huard, Julien Bissonnette, Marc Bilodeau
Current Hepatology Reports.2015; 14(3): 203.     CrossRef